Abstract
The coronavirus disease 2019 (COVID-19) pandemic is caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The spike protein (S) of SARS-CoV-2 is a major target for diagnosis and vaccine development because of its essential role in viral infection and host immunity. Currently, time-dependent responses of humoral immune system against various S protein epitopes are poorly understood. In this study, enzyme-linked immunosorbent assay (ELISA), peptide microarray, and antibody binding epitope mapping (AbMap) techniques were used to systematically analyze the dynamic changes of humoral immune responses against the S protein in a small cohort of moderate COVID-19 patients who were hospitalized for approximately two months after symptom onset. Recombinant truncated S proteins, target S peptides, and random peptides were used as antigens in the analyses. The assays demonstrated the dynamic IgM- and IgG recognition and reactivity against various S protein epitopes with patient-dependent patterns. Comprehensive analysis of epitope distribution along the spike gene sequence and spatial structure of the homotrimer S protein demonstrated that most IgM- and IgG-reactive peptides were clustered into similar genomic regions and were located at accessible domains. Seven S peptides were generally recognized by IgG antibodies derived from serum samples of all COVID-19 patients. The dynamic immune recognition signals from these seven S peptides were comparable to those of the entire S protein or truncated S1 protein. This suggested that the humoral immune system recognized few conserved S protein epitopes in most COVID-19 patients during the entire duration of humoral immune response after symptom onset. Furthermore, in this cohort, individual patients demonstrated stable immune recognition to certain S protein epitopes throughout their hospitalization period. Therefore, the dynamic characteristics of humoral immune responses to S protein have provided valuable information for accurate diagnosis and immunotherapy of COVID-19 patients.
Keywords: AbMap; COVID-19; ELISA; S protein; SARS-CoV-2; dynamics; epitope; microarray.
【저자키워드】 COVID-19, SARS-CoV-2, S protein, Dynamics, ELISA, epitope, microarray., AbMap, 【초록키워드】 coronavirus disease, IgG, IgM, Vaccine development, coronavirus, pandemic, Hospitalized, Hospitalization, Immunotherapy, Infection, peptide, Diagnosis, immune system, immune, Spike protein, Moderate COVID-19, Novel coronavirus, Antigen, Cohort, IgG antibody, Characteristics, response, Patient, peptides, Microarray, humoral immune response, distribution, information, change, COVID-19 patients, Analysis, recombinant, COVID-19 patient, humoral, symptom onset, acute respiratory syndrome, genomic region, domains, host immunity, S proteins, peptide microarray, S1 protein, random, serum sample, enzyme-linked immunosorbent, Seven, Comprehensive, caused, conserved, provided, were used, in viral, demonstrated, suggested, comparable, the S protein, reactivity, analyses, spike gene sequence, antibody binding epitope, homotrimer, S protein epitope, 【제목키워드】 spike, response, Assessing,